Clinical Trial Update: PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates that PYLARIFY PET/CT or PET/MRI is being studied in men with favorable intermediate-risk prostate cancer and the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Prostate Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING